Submission Deadline 10/25/2027
Fiscal Capacity $375,000
| Opportunity Number | PAR-27-078 |
|---|---|
| Agency | HHS-NIH11 |
| Application Deadline | 10/25/2027 |
| Award Amount | $375,000 |
| Status | Posted |
| Sector | Health |
| Cost Sharing | Not Required |
Fiscal Parameters & Taxonomy
Authority HHS-NIH11
Status Posted
Who Can Apply
Private institutions of higher education Public and State controlled institutions of higher education
Eligibility Intelligence
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Program Description
The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for health professional, undergraduate and graduate students and enhancing the research environment at applicant institutions.Eligible institutions must award baccalaureate or advanced science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the schools and colleges within the institution as a whole.Help determining the Organization Funding Level can be found here or https://grants.nih.gov/grants/funding/r15.htmThis REAP Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For purposes of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.
CFDA Programs
93.172 Human Genome Research
93.173 Research Related to Deafness and Communication Disorders
93.233 National Center on Sleep Disorders Research
93.242 Mental Health Research Grants
93.273 Alcohol Research Programs
93.279 Drug Use and Addiction Research Programs
93.307 Minority Health and Health Disparities Research
93.361 Nursing Research
93.393 Cancer Cause and Prevention Research
93.394 Cancer Detection and Diagnosis Research
93.395 Cancer Treatment Research
93.399 Cancer Control
93.837 Cardiovascular Diseases Research
93.838 Lung Diseases Research
93.839 Blood Diseases and Resources Research
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
93.865 Child Health and Human Development Extramural Research
93.866 Aging Research
93.867 Vision Research
Agency Contact
National Institute on Aging (NIA) NIA-NOFO-GrantsContacts@nih.gov
✉ NIA-NOFO-GrantsContacts@nih.gov📞 301-402-2541
Related Intelligence Guides
In-depth editorial guides covering this agency's programs, eligibility requirements, and application strategies.